NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis

Journal of Clinical Investigation

Volumn 123, Issue 11, 2013, Pages 4731-4738

  Goettsch, Claudia ^a,b   Babelova, Andrea ^c   Trummer, Olivia ^d   Erben, Reinhold G ^e   Rauner, Martina ^a   Rammelt, Stefan ^a,f   Weissmann, Norbert ^g   Weinberger, Valeska ^c   Benkhoff, Sebastian ^c   Kampschulte, Marian ^h   Obermayer Pietsch, Barbara ^d   Hofbauer, Lorenz C ^a,f   Brandes, Ralf P ^c   Schröder, Katrin ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c GOETHE UNIVERSITY   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^f CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^g JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^h UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLONY STIMULATING FACTOR 1; GKT 137928; OSTEOCLAST DIFFERENTIATION FACTOR; OXIDOREDUCTASE INHIBITOR; PAMIDRONIC ACID; PROTEIN C JUN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; FEMALE; GENE LOSS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRABECULAR BONE;

EID: 84887489588     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67603     Document Type: Article

References (40)

1. Hsu H, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A. 1999;96(7):3540-3545.
2. Woo KM, Kim HM, Ko JS. Macrophage colonystimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L). Exp Mol Med. 2002;34(5):340-346.
3. Kong YY, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397(6717):315-323.
4. Lacey DL, et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol. 2000;157(2):435-448.
5. Burgess TL, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 1999;145(3):527-538.
6. Yan T, Riggs BL, Boyle WJ, Khosla S. Regulation of osteoclastogenesis and RANK expression by TGF-β1. J Cell Biochem. 2001;83(2):320-325.
7. Sturrock A, et al. Transforming growth factorbeta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006;290(4):L661-L673.
8. Takac I, et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem. 2011;286(15):13304-13313.
9. Schroder K, Wandzioch K, Helmcke I, Brandes RP. Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol. 2009;29(2):239-245.
10. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest. 1990;85(3):632-639.
11. Hwang SY, Putney JW. Calcium signaling in osteoclasts. Biochim Biophys Acta. 2011;1813(5):979-983.
12. Lee NK, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood. 2005;106(3):852-859.
13. Sasaki H, et al. NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J Med Invest. 2009;56(1-2):33-41.
14. Laleu B, et al. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem. 2010;53(21):7715-7730.
15. Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007; 40(2):251-264.
16. Obermayer-Pietsch BM, et al. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res. 2004;19(1):42-47.
17. Manolagas SC. Steroids and osteoporosis: the quest for mechanisms. J Clin Invest. 2013;123(5):1919-1921.
18. Banfi G, Iorio EL, Corsi MM. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med. 2008;46(11)1550-1555.
19. Jiang F, Zhang Y, Dusting GJ. NADPH oxidasemediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev. 2011;63(1):218-242.
20. Zhou S, et al. BAPTA-AM, an intracellular calcium chelator, inhibits RANKL-induced bone marrow macrophages differentiation through MEK/ERK, p38 MAPK and Akt, but not JNK pathways. Cytokine. 2010;52(3):210-214.
21. Kajiya H, et al. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations. Cell Calcium. 2010;48(5):260-269.
22. Chamoux E, Bisson M, Payet MD, Roux S. TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption. J Biol Chem. 2010;285(33):25354-25362.
23. Mentaverri R, Kamel S, Brazier M. Involvement of capacitive calcium entry and calcium store refilling in osteoclastic survival and bone resorption process. Cell Calcium. 2003;34(2):169-175.
24. Miller BA, Zhang W. TRP channels as mediators of oxidative stress. Adv Exp Med Biol. 2011;704:531-544.
25. Tong X, Hou X, Jourd'heuil D, Weisbrod RM, Cohen RA. Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ Res. 2010; 107(8):975-983.
26. Gooch JL, Gorin Y, Zhang BX, Abboud HE. Involvement of calcineurin in transforming growth factorbeta-mediated regulation of extracellular matrix accumulation. J Biol Chem. 2004;279(15):15561-15570.
27. Kim MS, et al. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. J Biol Chem. 2010;285(10):6913-6921.
28. Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998;273(22):13367-13370.
29. Pare G, et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ Cardiovasc Genet. 2009;2:142-150.
30. Asagiri M, et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 2005;202(9):1261-1269.
31. Cross JV, Templeton DJ. Regulation of signal transduction through protein cysteine oxidation. Antioxid Redox Signal. 2006;8(9-10):1819-1827.
32. Yang S, Zhang Y, Ries W, Key L. Expression of Nox4 in osteoclasts. J Cell Biochem. 2004;92(2):238-248.
33. Liu RM, et al. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem. 2010;285(21):16239-16247.
34. Carlson J, et al. Role of MKP-1 in osteoclasts and bone homeostasis. Am J Pathol. 2009;175(4):1564-1573.
35. Aoyama T, et al. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology. 2012;56(6):2316-2327.
36. Loeser RF. Aging and osteoarthritis. Curr Opin Rheumatol. 2011;23(5):492-496.
37. Gugatschka M, et al. Molecularly-defined lactose malabsorption, milk consumption and anthropometric differences in adult males. QJM. 2005;98(12):857-863.
38. Zhang M, et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A. 2010;107(42):18121-18126.
39. Indra AK, et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifeninducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 1999;27(22):4324-4327.
40. Chang J, et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med. 2009; 15(6):682-689.